Vincent is currently a Project Manager within the PROTECT portfolio with a focus on Good Clinical Practice and Quality Assurance within the commercial sector. With three and a half years experience in clinical Data Management, he has been managing the University of Exeter’s components of two commercial clinical trials; SOUL with Novo Nordisk and REMAD with reMYND since April 2023. Through these projects, he has acquired substantial experience of international trial management related to online cognitive test system delivery, as well as computer systems validation required for regulatory compliance. Additionally, Vincent supports the medical device regulatory component of the NIHR funded project, ReaCTIVE, which will provide clinical validation of an app looking at early detection of dementia.

Having gained a BSc in Medical Sciences in 2017, Vincent has a keen interest in medical research and has contributed to the following publications:

Corbett A, Creese B, Hayman V, Palmer A, Filakovsky A, Ballard C (2023). Cognitive decline in older adults during and after the COVID-19 pandemic: a longitudinal analysis of the PROTECT UK study data. The Lancet Healthy Longevity

Brooker H, Hayman V, Aarsland D, Creese B, Ballard C, Corbett A (2021). Impact of brisk walking on cognitive decline in adults with and without early impairment: a FLAME analysis in the PROTECT cohort. Alzheimer's & Dementia, 17(S10).

Brooker H, Hayman V, Aarsland D, Creese B, Ballard C, Corbett A (2021). The impact of the COVID‐19 pandemic on cognitive health. Alzheimer's & Dementia: the journal of the Alzheimer's Association, 17(Suppl 10). Abstract.